Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Rheumatology Education Healthcare Disparities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Equity in Access to Cancer Cachexia Clinical Trials
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Infectious Disease Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Hospital India
    Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: Arabic (link)
    Translation: French (link)
    Translation: Mandarin (link)
    Translation: Spanish (link)
    Quality Improvement Rare Disease All
    2022 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines USA
    New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Improving the Care of Patients with Disorders of Impaired Growth
    Release Date:
    Partner: ICOSEP
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All